Explore more topics
SEC Form 4 research

Elevance Health, Inc. insider transactions

Inspect Elevance Health, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001156039
Reporting owners
79
Officers and directors
53
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-062026-10-02Kaye MarkA2,627$0Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-10-02 and its public availability date is 2026-10-06. Subtracting those calendar dates gives 4 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code A: a award. An award is an acquisition but is not an open-market purchase. A purchase-following rule must not count it as code P.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 4 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-062026-10-02Kaye MarkA2,627$0Not reported
2026-07-182026-07-17BOUDREAUX GAILP2,045$368.25Not reported
2026-07-182026-07-17BOUDREAUX GAILP680$366.41Not reported
2026-07-182026-07-17PERU RAMIRO GP1,000$366.05Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 50 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

Braly Angela F00013214582
LEWIS RANDALL J000112348524
LISS VICTOR S00011920759
BURKE SHEILA P000119720932
Penczek Ronald W000165907529
GLASSCOCK LARRY C0001189793375
DeVore Susan D.00015876977
COLLIS STEVEN H0001191508141
Haytaian Peter D000160853857
BOUDREAUX GAIL000128792028
Beer Lori A000143667718
MCCARTHY GLORIA M000120367149
ZORETIC RICHARD C000126371434
PERU RAMIRO G000119204544
Tomas Jose D.00015522921
DeVeydt Wayne S000132139237
Goulet Kenneth R000141551622
BAKER LENOX D JR MD00012019423
BAYH SUSAN B000119208331
BOXER MARK L000123850613
Brown Randal L000132143515
BUSH WILLIAM H T00012433915
Cannon John00014215459
Dixon Robert L JR000152484914
DORR MARJORIE W000119420828
FALLER KEITH R000119209730
Fluegel Bradley M00014155153
Gallina John E000143303216
GRIFFIN BRIAN T000125200643
HELWIG DAVID S000124340358
HERMAN JOAN E000124839847
HILL JULIE A000124339425
JOBE WARREN Y000123102018
Kaye Mark000174869126
Kendrick Charles Morgan JR000188790810
Levine Harlan A00015260391
Lewis Dijuana K00013375543
MAYS WILLIAM G00011808829
Miller Cynthia S00014253761
Miller Martin L00013326712
Norwood Felicia F00017435484
NUSSBAUM SAMUEL R MD000119931027
PISANO JANE G00012433964
RIEGLE DONALD W JR000119582914
ROSENBLATT ALICE F0001243413240
RYAN WILLIAM J000119207840
Samitt Craig E00016018511
Sassi Brian A00014253285
SCHAEFER GEORGE A JR000119581112
Schneider Ryan M.000142050135

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.